| __timestamp | ADMA Biologics, Inc. | Amphastar Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5915545 | 210461000 |
| Thursday, January 1, 2015 | 7177633 | 251519000 |
| Friday, January 1, 2016 | 10661037 | 255165000 |
| Sunday, January 1, 2017 | 22760560 | 240175000 |
| Monday, January 1, 2018 | 16985290 | 294666000 |
| Tuesday, January 1, 2019 | 29349083 | 322357000 |
| Wednesday, January 1, 2020 | 42219783 | 349846000 |
| Friday, January 1, 2021 | 80942625 | 437768000 |
| Saturday, January 1, 2022 | 154079692 | 498987000 |
| Sunday, January 1, 2023 | 258214999 | 644395000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of biotechnology and pharmaceuticals, revenue growth is a key indicator of success. Over the past decade, ADMA Biologics, Inc. and Amphastar Pharmaceuticals, Inc. have demonstrated remarkable financial trajectories. From 2014 to 2023, ADMA Biologics saw its revenue skyrocket by over 4,200%, starting from a modest $5.9 million to an impressive $258 million. This growth reflects the company's strategic advancements in the biologics sector.
Conversely, Amphastar Pharmaceuticals, a leader in generic and specialty pharmaceuticals, experienced a robust 206% increase in revenue, reaching $644 million by 2023. This growth underscores Amphastar's strong market presence and its ability to adapt to industry demands. As these companies continue to innovate, their financial performance offers valuable insights into the dynamic nature of the pharmaceutical industry.
Annual Revenue Comparison: Merck & Co., Inc. vs ADMA Biologics, Inc.
Revenue Insights: Pfizer Inc. and Amphastar Pharmaceuticals, Inc. Performance Compared
Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
GSK plc vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
United Therapeutics Corporation and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Incyte Corporation and ADMA Biologics, Inc. Performance Compared
Bio-Techne Corporation vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Walgreens Boots Alliance, Inc. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Exelixis, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
TG Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Annual Revenue Comparison: ADMA Biologics, Inc. vs Veracyte, Inc.
Revenue Insights: ADMA Biologics, Inc. and Bausch Health Companies Inc. Performance Compared